 |
|
| ADVANCES IN CANCER RESEARCH, 85
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
George Klein, Karolinska Insitutet, Stockholm, Sweden
Included in series
Advances in Cancer Research,
Audience
Researchers and students in the basic and clinical science of cancer biology and oncology, genetics, immunology, pharmacology, cell and molecular biology.
Contents
The Von Hippel-Lindau Tumor Suppressor Complex and Regulation of Hypoxia-Inducible Transcription. Retinoblastoma Tumor Suppressor and
Genome Stability.
The Abl Family Kinases: Mechanisms of Regulation and Signaling.
Cellular Immunity to the Her-2/neu Proto-oncogene.
A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance.
Cell Volume and Ion Changes During Apoptotic Cell Death.
Mitochondria and Apoptosis: New Therapeutic Targets.
| Bibliographic details |
Hardbound, 251 pages, publication date: SEP-2002
ISBN-13: 978-0-12-006685-8
ISBN-10: 0-12-006685-8
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 15 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company